I agree. trial details were suggested to being released in Q1 this year...we are now half way through Q3 none the wiser.........Study design and sample size would not be that difficult to determine. There may be another reason (???FDA acceptance of the design??) for the delay in the details being released.....
- Forums
- ASX - By Stock
- Clinical trials
I agree. trial details were suggested to being released in Q1...
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$14.25 |
Change
0.740(5.48%) |
Mkt cap ! $301.2M |
Open | High | Low | Value | Volume |
$13.60 | $14.25 | $13.35 | $309.6K | 22.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1150 | $14.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.25 | 314 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1150 | 14.100 |
1 | 364 | 13.700 |
1 | 100 | 13.400 |
1 | 60 | 13.150 |
1 | 50 | 13.120 |
Price($) | Vol. | No. |
---|---|---|
14.250 | 314 | 1 |
15.000 | 1000 | 1 |
15.150 | 149 | 1 |
15.500 | 44 | 1 |
15.700 | 277 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |